Report of Foreign Issuer (6-k)
31 October 2019 - 12:02AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of October 2019
Commission File Number 001-37410
ESSA Pharma Inc.
(Translation of registrant’s name into
English)
Suite 720, 999 West Broadway, Vancouver,
British Columbia, Canada, V5Z 1K5
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x
Form 40-F ¨
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
EXPLANATORY NOTE
The following exhibits included herein were filed by the Registrant
with the Canadian securities regulatory authorities on the System for Electronic Document Analysis and Retrieval on the dates noted
below:
1.
|
Exhibit 99.1:
|
News Releases Dated October 30, 2019: ESSA Pharma Grants Stock Options
|
This report on Form 6-K shall be incorporated by reference into the registrant’s Registration Statements
on Form F-3 (File No. 333-222654) and Form S-8 (File No. 333-225056) under the Securities Act of 1933, as amended.
EXHIBITS INCLUDED AS PART OF THIS REPORT
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
|
|
|
|
|
|
|
ESSA
PHARMA INC.
|
|
|
(Registrant)
|
|
|
|
Date: October 30,
2019
|
|
By:
|
|
/S/
DAVID WOOD
|
|
|
Name:
Title:
|
|
David Wood
Chief Financial Officer
|
ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart
From Apr 2024 to May 2024
ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart
From May 2023 to May 2024